Beverly E Sha
Affiliation: Rush University Medical Center
- Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individualsShilpa M Patel
Veterans Affairs Chicago Healthcare System Lakeside Division, Chicago, IL, USA
J Acquir Immune Defic Syndr 35:120-5. 2004..Because of its favorable pharmacokinetic profile, non-HIV-infected individuals have received nevirapine-containing postexposure prophylaxis (PEP)...
- Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitutionGregory D Huhn
Division of Infectious Diseases, The Ruth M, Rothstein CORE Center, 2020 W, Harrison St, Chicago, Illinois, 60612, USA
AIDS Res Ther 7:44. 2010..abstract:..
- Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominisBeverly E Sha
Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, University of Illinois at Chicago, Illinois, USA
J Infect Dis 191:25-32. 2005..Bacterial vaginosis (BV) is associated with human immunodeficiency virus (HIV) acquisition. We examined the association between BV and BV-associated bacteria and expression of HIV in the female genital tract...
- Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected womenBeverly E Sha
Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, Chicago, IL 60612, USA
J Clin Microbiol 43:4607-12. 2005..In this cohort, Amsel criteria were poorly predictive of BV. PCR quantification of G. vaginalis and M. hominis from CVL is significantly more sensitive than Amsel criteria for diagnosing BV...
- Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2Beverly E Sha
Section of Infectious Diseases, Department of Medicine, Rush Medical College, Chicago, Illinois 60612 3833, USA
AIDS Res Hum Retroviruses 18:661-5. 2002..Pretreatment with etanercept may blunt activation of IL-6 and CRP expression induced by rhIL-2. The safety and utility of etanercept in HIV-infected persons should be explored further...
- Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitisBeverly E Sha
Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA
J Low Genit Tract Dis 11:240-50. 2007..We sought to determine whether the standard diagnostic methods for vaginitis behave similarly among HIV-infected and at-risk seronegative women...
- Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus loadM Reza Zariffard
Rush University Medical Center, Chicago, IL 60612
AIDS Res Hum Retroviruses 21:945-8. 2005..Thus, while these data show a strong association of U1 stimulatory activity with BV, no influence of the U1 activity on genital tract HIV expression was observed...
- Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominisM Reza Zariffard
Department of Immunology Microbiology, Rush University, 1653 West Congress Parkway, Chicago, IL 60612, USA
FEMS Immunol Med Microbiol 34:277-81. 2002....
- A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDSBarbara Swanson
Adult Health Nursing, Rush University College of Nursing, 600 South Paulina, Chicago, IL 60612, USA
Nutrition 18:688-90. 2002..We collected preliminary data on the safety and efficacy of supplemental arginine to improve natural killer cell cytotoxicity in a sample of persons with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)...
- Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected womenGregory T Spear
Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
J Reprod Immunol 78:76-9. 2008..G. vaginalis and M. hominis were not significantly associated with IL-8. This study has shown an association between C. albicans and levels of IL-8 in mucosal genital fluid...
- HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic courseAllan R Tenorio
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
J Acquir Immune Defic Syndr 34:491-6. 2003..HIV-specific CD4+ T-cell immunity was detected in most subjects with low-level and undetectable viremia and may have a role in controlling viremia in the setting of partial suppression...
- Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapyBarbara Swanson
Department of Adult Health Nursing, Rush University College of Nursing, Chicago, Illinois, USA
Nutrition 20:1022-5. 2004....
- Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trialBarbara Swanson
Rush University College of Nursing, Chicago, Illinois, USA
Altern Ther Health Med 17:30-5. 2011..Policosanol is a dietary supplement derived from sugar cane that is widely used as a statin alternative in Latin America...
- A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemiaJoyce K Keithley
Rush University College of Nursing, Chicago, Illinois 60612, USA
Nutrition 18:201-4. 2002..We collected preliminary safety and efficacy data on the effects of Cholestin, a statin-containing dietary supplement, in individuals with dsylipidemia related to human immunodeficiency virus...
- Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosisM Reza Zariffard
Department of Immunology and Microbiology, Rush University, Chicago, Illinois 60612, USA
J Infect Dis 191:1913-21. 2005..Bacterial vaginosis (BV) is associated with complications of pregnancy and increased susceptibility to human immunodeficiency virus (HIV) sexual transmission...
- Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapyRohit Talwani
Section of Infectious Diseases, Department of Medicine, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
J Acquir Immune Defic Syndr 30:191-5. 2002..These results need to be confirmed in larger long-term studies, with controls well matched for coronary risk factors...
- Kikuchi-Fujimoto disease: hydroxychloroquine as a treatmentKatayoun Rezai
Section of Infectious Diseases, Department of Medicine, John H Stroger Hospital of Cook County, Chicago, IL 60612, USA
Clin Infect Dis 39:e124-6. 2004..We describe a case of recurrent Kikuchi's disease in a South Asian-American man that was treated successfully with chloroquine and on recurrence with hydroxychloroquine. Each treatment led to a very prompt response...
- Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two casesMichael Y Lin
Section of Infectious Diseases, Rush University Medical Center, Chicago, IL 60612, USA
Mycoses 53:356-9. 2010..dermatitidis, particularly of the extremity muscles, is unique. We conclude that B. dermatitidis is a potential cause of classic pyomyositis...
- Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12Beverly E Sha
Department of Medicine, Section of Infectious Diseases, Rush Medical College, Chicago, IL, USA
AIDS 18:1203-6. 2004..Three responders had received IL-12, suggesting a possible adjuvant effect of Il-12. Transient mild injection site reactions (7.9) and systemic symptoms (3/9) occurred...
- Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150Beverly E Sha
Section of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA
HIV Clin Trials 12:9-23. 2011..The AIDS Clinical Trials Group (ACTG) A5150 study was designed to characterize the incidence of viral load rebound during the immediate 24 weeks postpartum and explore factors associated with viral load rebound...
- HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infectionJun Fu
Department of Immunology Microbiology, Rush Medical College, Chicago, IL 60612, USA
J Acquir Immune Defic Syndr 56:16-25. 2011..Here, we evaluated the effect of the local milieu created by activated PBMC before and after HIV-1 infection on neutrophil survival and HLA-DR expression, with emphasis placed on a role for GM-CSF...
- Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trialJoyce K Keithley
Rush University College of Nursing, Illinois, Chicago, USA
JPEN J Parenter Enteral Nutr 26:6-14. 2002..A secondary aim was to evaluate the feasibility of maintaining a diverse sample of outpatients on a long-term oral formula protocol...
- Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapyGrace A McComsey
Case Western Reserve University, Cleveland, Ohio 44106, USA
HIV Clin Trials 9:126-36. 2008..The effects of gestational nucleoside reverse transcriptase inhibitors (NRTIs) on mitochondrial DNA (mtDNA) are controversial. The effects of mtDNA depletion on mitochondrial function have not been assessed...
- Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapyRichard T Davey
National Institutes of Health, National Institute of Allergy and Infectious Disease, Bethesda, MD 20892, USA
J Interferon Cytokine Res 28:89-100. 2008..Bay 50-4798 was generally well tolerated across the dose range tested, but a lack of potent, sustained immunologic activity suggests that further optimization of dose and schedule will be necessary...
- Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected womenKimberly Battle-Miller
Department of Microbiology and Immunology, Finch University of Health Sciences The Chicago Medical School, North Chicago, IL 60064, USA
J Infect Dis 185:439-47. 2002..ADCC antibodies are present in the cervicovaginal fluids, which indicates that this form of innate immunity can contribute to mucosal defense against HIV-1...
- Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patientsOluwatoyin M Adeyemi
J Acquir Immune Defic Syndr 49:113-4. 2008